ImmunityBio, Inc. IBRX Weighted-Average Discount Rate - Finance Leases
Weighted-Average Discount Rate - Finance Leases at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s weighted-average discount rate - finance leases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ImmunityBio, Inc.'s weighted-average discount rate - finance leases?
- ImmunityBio, Inc. (IBRX) reported weighted-average discount rate - finance leases of $0.12 in Q1 2026.
- What is the long-term trend for ImmunityBio, Inc.'s weighted-average discount rate - finance leases?
- Over 3 years (2022 to 2025), ImmunityBio, Inc.'s weighted-average discount rate - finance leases has grown at a -0.3% compound annual growth rate (CAGR), from $0.12 to $0.12.